Common Stock, Shares Authorized of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Common Stock, Shares Authorized for the quarter ending 30 Jun 2023 was 950,000,000, a 90% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 950,000,000 +450,000,000 +90% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 600,000,000 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 500,000,000 0 0% 31 Dec 2022 10-Q 09 Aug 2023 2023 Q2
Q2 2022 500,000,000 30 Jun 2022 6-K 29 Aug 2022 2022 Q2
Q4 2021 500,000,000 +217,575,009 +77% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 282,424,991 31 Dec 2020 20-F 26 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.